openPR Logo
Press release

Interspinous Spacer Market 2024 Trends, Challenges and Growth Drivers Analysis

04-19-2017 06:31 AM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Interspinous Spacer Market 2024 Trends, Challenges and Growth

Interspinous spacers sometimes also called as Interspinous process decompression systems, are the devices implanted between vertebral spinous processes. These spacers are made up of a very strong but lightweight metal (titanium) which is biocompatible in the human body. These devices are imbedded in body to confine painful motion else enabling normal motion and to treat lumbar spinal stenosis, discogenic low-back pain, facet syndrome, disc herniations, and non-traumatic instability. Lumbar spinal stenosis is a thinning of the spinal canal in the lower back which causes compression on nerves and it is developed gradually with age. Radiology tests are used to confirm a diagnosis of moderate degenerative lumbar spinal stenosis. People with lumbar spinal stenosis experience pain but may also have weakness in their leg, lower back and buttocks, numbness, tingling.

Browse the Complete Report Details at: http://www.transparencymarketresearch.com/interspinous-spacer-market.html

The Interspinous spacer are implanted between those vertebrae in such a way that it prevents the patient from bending too far backward which causes pain by surgical procedure. The procedure is very small and sometimes patient can go home within a day.

The increasing prevalence of spinal stenosis due to aging, arthritis, heredity and increased demand of surgical procedures that improved lifestyle and comfort will drive the Interspinous spacer market. The adoption of spacers are increasing due to low complication rate as compared to decompression and spinal fusion. The Interspinous spacers are widely used in geriatric population as per Medicare data due to old age patient are not comfortable with surgery due to their health conditions.

The Interspinous spacer market is segmented as device type, end user and geography. The product type segment is further divided in two type’s statics or compressible and dynamic or non-compressible respectively. The examples of static devices include X STOP, ExtenSure and Wallis implants. These are made up of non-compressible material such as bone, metal or synthetics. The devices produce constant amount of distraction between the spinous processes due to their non-compressible nature. Dynamic Interspinous spacer devices have a degree of compressibility. The example of dynamic devices is Coflex device formally known as Interspinous ‘U.’ it is U shaped piece of metal composed of axially compressible, which is interposed between the spinous processes. It is inserted in a compressed mode so that it exerts a distraction force between the bones. As the devices are technologically improved devices hence the market of Interspinous spacer will grow in the forecast period due to high adoption of technology in developed as well as developing countries. However, the Interspinous spacers have risk such as dislodged of implant, or sometimes requires additional surgery for the management of pain or other symptoms, which may anticipate the growth of market.

On the basis of end user the market is segmented as hospital, orthopedic clinics, Ambulatory surgical centers and the counter products. The orthopedic clinics segment can attribute to growth of market followed by hospitals and ambulatory surgical centers.

Geographically the global market for Interspinous spacer is segmented as North America, Latin America Europe, Asia pacific, and Middle East and Africa. The rising elderly population will govern the market of North America. The developing countries are the key market for Interspinous spacer market because of enhancement in quality of life and awareness in people about products.

The key players of market for Interspinous spacer devices are VertiFlex, Inc., IMECO, Medyssey Co. Ltd, Zimmer Inc., Depuy Synthes, Precision Spine, Life Spine, NuVasive, Abbott Spine. Companies adopting the strategies like enhancing technologies and innovative products to compete in market. Vertiflex Inc. is a leading innovator of advanced minimally invasive interventions for spinal stenosis, and recently launched new product Superion for the Interspinous spacer system.

Get the Sample PDF Report for the Future Trends of this Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16439

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Interspinous Spacer Market 2024 Trends, Challenges and Growth Drivers Analysis here

News-ID: 506096 • Views: 2567

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases